CRWD(CRWD)
CRWD
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
| Metric | FY2027E | FY2028E | FY2029E | FY2030E | FY2031E |
|---|---|---|---|---|---|
| Revenue Avg | $5.94B | $7.23B | $8.76B | $10.22B | $11.98B |
| Low | $5.90B | $7.09B | $8.74B | $10.02B | $11.75B |
| High | $6.00B | $7.38B | $8.77B | $10.41B | $12.21B |
| EBITDA Avg | $926M | $1.13B | $1.37B | $1.59B | $1.87B |
| Low | $920M | $1.11B | $1.36B | $1.56B | $1.83B |
| High | $936M | $1.15B | $1.37B | $1.62B | $1.90B |
| EBIT Avg | $498M | $606M | $734M | $857M | $1.00B |
| Low | $495M | $594M | $733M | $840M | $985M |
| High | $503M | $619M | $736M | $873M | $1.02B |
| Net Income Avg | $1.29B | $1.77B | $2.01B | $2.34B | $2.55B |
| Low | $1.27B | $1.50B | $1.06B | $2.28B | $2.48B |
| High | $1.30B | $2.03B | $2.95B | $2.39B | $2.61B |
| EPS Avg | $4.94 | $6.25 | $8.06 | $9.05 | $9.87 |
| Low | $4.92 | $5.82 | $4.12 | $8.81 | $9.62 |
| High | $5.05 | $7.86 | $11.42 | $9.27 | $10.11 |
| Analysts (Rev / EPS) | 38 / 25 | 38 / 27 | 20 / 8 | 11 / 3 | 10 / 4 |
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $1.44B | $1.51B | $1.60B | $1.69B | $1.75B | $1.84B | $1.94B | $2.05B |
| Low | $1.43B | $1.50B | $1.59B | $1.68B | $1.74B | $1.83B | $1.93B | $2.04B |
| High | $1.45B | $1.52B | $1.61B | $1.70B | $1.77B | $1.85B | $1.96B | $2.07B |
| EBITDA Avg | $225M | $236M | $250M | $263M | $273M | $287M | $303M | $320M |
| Low | $223M | $235M | $248M | $262M | $272M | $285M | $301M | $318M |
| High | $226M | $238M | $252M | $265M | $275M | $289M | $305M | $322M |
| EBIT Avg | $121M | $127M | $134M | $141M | $147M | $154M | $163M | $172M |
| Low | $120M | $126M | $134M | $141M | $146M | $153M | $162M | $171M |
| High | $122M | $128M | $135M | $143M | $148M | $155M | $164M | $173M |
| Net Income Avg | $302M | $320M | $364M | $361M | $382M | $401M | $447M | $462M |
| Low | $299M | $310M | $361M | $358M | $379M | $398M | $443M | $459M |
| High | $307M | $325M | $367M | $365M | $386M | $405M | $451M | $467M |
| EPS Avg | $1.17 | $1.24 | $1.41 | $1.40 | $1.48 | $1.56 | $1.73 | $1.79 |
| Low | $1.16 | $1.20 | $1.40 | $1.39 | $1.47 | $1.55 | $1.72 | $1.78 |
| High | $1.19 | $1.26 | $1.42 | $1.41 | $1.50 | $1.57 | $1.75 | $1.81 |
| Analysts (Rev / EPS) | 28 / 27 | 28 / 27 | 14 / 14 | 26 / 17 | 18 / 20 | 14 / 23 | 13 / 25 | 13 / 13 |